Isoptin Retard (Verapamil Hydrochloride)

Verapamil hydrochloride blocks L‑type calcium channels in cardiac and vascular smooth‑muscle cells. This inhibition reduces calcium entry, leading to decreased myocardial contractility, slowed atrioventricular nodal conduction, and peripheral vasodilation, which together lower heart rate and blood pressure.

The appropriate dose of Isoptin Retard is individualized by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any relevant comorbidities. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Isoptin Retard in pregnancy and lactation has not been established. Clinicians must weigh potential benefits against possible risks, and it is generally reserved for situations where alternative therapies are unsuitable and the therapeutic advantage justifies exposure.

To order Isoptin Retard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Isoptin Retard belongs to the non‑dihydropyridine class, which primarily affects cardiac conduction and contractility, whereas dihydropyridine agents (e.g., amlodipine) mainly cause peripheral vasodilation. This makes Isoptin Retard especially useful for rate control in arrhythmias, while dihydropyridines are often chosen for pure antihypertensive effects.

Isoptin Retard tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Isoptin Retard is taken orally as an extended‑release tablet, usually with or without food as directed by the prescriber. The tablet should be swallowed whole; it must not be split, crushed, or chewed to preserve the controlled‑release properties.

Serious adverse events include bradycardia, heart block, and severe hypotension. Patients should report symptoms such as unusually slow heartbeats, fainting, dizziness, or chest discomfort promptly, as these may indicate the need for medical evaluation or dose adjustment.

Isoptin Retard is contraindicated in patients with known hypersensitivity to verapamil or any excipients, those with severe hypotension, advanced heart block without a pacemaker, and certain forms of cardiogenic shock. Clinicians should also exercise caution in patients with severe heart failure or hepatic impairment.